Catalyst Pharmaceuticals
CPRX
#3685
Rank
NZ$4.81 B
Marketcap
$39.64
Share price
-2.49%
Change (1 day)
45.04%
Change (1 year)

Earnings for Catalyst Pharmaceuticals (CPRX)

Earnings in 2024 (TTM): NZ$0.30 Billion

According to Catalyst Pharmaceuticals's latest financial reports the company's current earnings are NZ$0.46 Billion. In 2023 the company made an earning of NZ$0.16 Billion a decrease over its 2022 earnings that were of NZ$0.18 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Catalyst Pharmaceuticals from 2007 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) NZ$0.30 B81.26%
2023 NZ$0.16 B-9.75%
2022 NZ$0.18 B98.83%
2021 NZ$93.54 M25.73%
2020 NZ$74.4 M25.38%
2019 NZ$59.34 M-198.25%
2018 -NZ$60.4 Million84.68%
2017 -NZ$32.71 Million1.88%
2016 -NZ$32.11 Million-10.68%
2015 -NZ$35.94 Million30.46%
2014 -NZ$27.55 Million27.6%
2013 -NZ$21.59 Million198.17%
2012 -NZ$7.25 Million-36.22%
2011 -NZ$11.36 Million59.52%
2010 -NZ$7.12 Million-44.68%
2009 -NZ$12.87 Million-31.45%
2008 -NZ$18.77 Million155.21%
2007 -NZ$7.36 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
NZ$0.69 B 107.35%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.22 B-31.46%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$30.98 B 9,138.89%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.49 Billion-243.96%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$12.33 B 3,577.65%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$12.03 B 3,490.25%๐Ÿ‡บ๐Ÿ‡ธ USA